Investing.com - Lucid Capital Markets initiated coverage on SS Innovations Int’l (NASDAQ:SSII) with a Buy rating and a price target of $7.00. The target represents significant upside from the current stock price of $4.01, though shares have declined 35% over the past six months.
The firm highlighted the company’s Mantra 3 robotic surgical system, which is priced at approximately half the cost of an Intuitive Surgical da Vinci robot. The system is designed as a multispecialty platform including cardiac procedures.
Since its launch at the end of 2023, the company has completed 194 robotic installs and 10,500 cumulative procedures across 9 specialties and more than 100 validated procedure types.
The system features a modular design allowing for 3, 4, or 5 arms, an open-faced console, and a full instrument suite with more than 40 SSi Mudra instruments.
Lucid Capital Markets stated the platform represents a viable alternative for non-U.S. markets, as well as U.S. Ambulatory Surgical Centers and community hospitals. The company posted revenue of $48.5 million with 119% growth in the last twelve months, though InvestingPro notes it remains unprofitable with additional insights available for subscribers.
In other recent news, SS Innovations International has made significant strides with its SSi Mantra surgical robotic system, receiving regulatory approvals in Colombia, Oman, Sri Lanka, and Kenya. These approvals mark a key milestone for the company as it expands its presence in international markets. Additionally, SS Innovations successfully completed a private placement, raising approximately $18.6 million in gross proceeds. This capital raise involved the sale of 5,774,839 shares of common stock, with notable investments from company insiders, including $2.0 million each from Chairman and CEO Dr. Sudhir Srivastava and Vice-Chairman Dr. Frederic H. Moll.
Meanwhile, UberDoc Health Technologies has announced the appointment of John Dvor to its board of directors. Dvor brings a wealth of experience in medical innovation and healthcare technology, having previously held roles with C10 Labs and SS Innovations International. He co-founded Tufts Health Ventures and has a distinguished background, including service in the U.S. Marine Corps. These developments reflect ongoing strategic initiatives and leadership enhancements within both companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy. Get the bottom line for SSII plus thousands of other stocks and find your next hidden gem with massive upside.